DBT Bureau
Bengaluru, 10 January 2025
The legal tussle between Infosys and Cognizant has escalated as Infosys has now sued Cognizant in the US court alleging that Cognizant and its CEO, Ravi Kumar indulged in anti-competitive activities for maintaining the latter’s monopoly in healthcare software solution space.
The case was filed in the Northern District of Texas, and alleged that Kumar misused sensitive information to slow down the competitive positioning of Infosys’s healthcare platform, Helix. Infosys has requested a jury trial and demanded triple the damages it claims to have suffered.
The case was a countersuit against Cognizant’s earlier case filed in 2024, which accused Infosys of stealing trade secrets related to its healthcare insurance software.
Infosys alleged that Kumar, who spearheaded the development and sales of its healthcare platform Helix during his stint at Infosys, was privy to all its confidential details. Infosys alleged that Kumar deliberately slowed down the launch of the platform.
“His decisions effectively meant that, at the time, Infosys ‘cannot do any new development’ for Infosys Helix,” the lawsuit stated.
Infosys further alleged that after Kumar’s departure, senior executives such as Shveta Arora and Ravi Kiran Kuchibhotla also joined Cognizant.
Infosys also alleged that Cognizant was abusing its monopoly position in the US healthcare payer segment.
Infosys has been witnessing tepid growth in recent quarters though things had started improving from Q2FY25.
